查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087674

血管移植物市場：按產品類型、血管直徑、適應症、最終用戶和分銷管道分類的全球市場預測，2026-2032年

Vascular Graft Market by Product Type, Blood Vessel Diameter, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血管移植市場將成長至 27.8 億美元，複合年成長率為 6.44%。

主要市場統計數據
基準年 2025 18億美元
預計年份：2026年 19億美元
預測年份 2032 27.8億美元
複合年成長率 (%) 6.44%

血管移植市場概覽

由於心血管疾病、周邊動脈疾病、主動脈瘤修復、糖尿病相關血管併發症以及末期腎臟病等疾病的發展，人們對持久性血管通路和旁路手術的需求不斷成長，血管移植市場持續擴張。世界衛生組織（WHO）將心血管疾病列為全球首要死因。同時，國際糖尿病聯盟（IDF）和腎臟疾病相關文獻指出，糖尿病和慢性腎臟病的負擔日益加重，導致需要血液透析通路、重組和複雜血管重組的患者數量不斷增加。

血管移植領域的變革性變化

血管移植領域正經歷一場變革，其驅動力源自於對血管內治療、混合手術室、先進生物材料以及個人化治療方案日益成長的需求。儘管傳統的開放式旁路手術在許多複雜的血運重組病例中仍然至關重要，但血管內動脈瘤修復、周邊血管介入和混合修復策略的擴展正在改變產品的要求，例如移植物柔軟性、密封性能、抗扭轉性、縫線保持力以及與影像引導工作流程的兼容性。

人工智慧（AI）的累積影響

人工智慧 (AI) 正開始影響血管移植生態系統，從診斷和手術規劃到生產品管和術後監測，沒有例外。 AI 驅動的影像分析能夠輔助評估血管直徑、鈣化情況、病變形態、動脈瘤解剖結構、血流動力學以及入路部位的適宜性，從而幫助臨床醫生選擇合適的移植血管類型並製定更一致的介入治療方案。在透析通路和周邊繞道手術中，預測模型有助於識別移植血管功能障礙、狹窄、感染或再次介入治療的高風險患者。

主要區域洞察

北美地區憑藉其龐大的手術量、完善的保險報銷體系、先進的血管外科基礎設施以及對血管內和混合療法的積極應用，仍然是血管移植市場的主要區域。美國是該地區需求的主要驅動力，這主要得益於其高心血管疾病發生率、大規模的透析患者群體以及醫療設備創新的集中度。同時，加拿大則強調實證醫學採購、全民健保和專業的血管照護路徑。

關鍵群體特定見解

由於人口老化、完善的醫保報銷體系、成熟的血管外科醫療體系、先進的透析網路以及創新型移植技術的廣泛應用，七國集團（G7）對高價值血管移植的需求基礎雄厚。在歐盟，監管協調和跨境臨床證據的建立正在推進，醫療設備法規（MDR）的合規性正在加強對製造商的文件記錄、臨床評估和上市後監管的要求。

主要國家的概況

美國擁有最大的市場潛力，這得益於其龐大的血管手術量、大量的透析患者、先進的醫保報銷機制以及對尖端醫療技術的積極應用。加拿大憑藉著公共醫療體系和專業的血管中心，維持著穩定的需求。同時，墨西哥和巴西正透過其公私混合醫療體系、不斷提升的介入心臟病學能力以及日益成長的透析通路解決方案需求，擴大醫療服務的覆蓋範圍。

為行業領導者提供的實用建議

產業領導者應優先考慮差異化血管移植物的表現，並以臨床終點指標為支撐，例如初始通暢率、輔助通暢率、二次通暢率、感染率降低、肢體保留率、再次干預率和患者存活率。投資於抗菌塗層、肝素結合表面、生物工程移植物、組織工程血管移植物和小直徑移植物創新技術，可以解決周邊旁路和透析通路領域長期存在的未滿足需求。

調查方法

本執行摘要基於系統性的二手研究途徑，並遵循既定的市場情報分析標準。研究資料包括衛生當局和監管機構的公開資訊、同行評審的臨床文獻、醫療設備指南、疾病負擔資料集、醫院醫療保健趨勢以及產品類型資訊披露。本分析重點檢驗的指標，例如心血管疾病盛行率、糖尿病和慢性腎臟病趨勢、透析通路需求、血管外科手術需求、監管趨勢以及技術採納模式。

結論

隨著醫療保健系統應對日益增多的心血管疾病、透析通路需求、周邊動脈疾病和動脈瘤修復等問題，血管移植物市場預計將保持其持續的戰略重要性。市場需求不僅受手術數量的影響，也受臨床證據、器械耐用性、感染預防、移植物通暢性、手術效率以及降低再次手術率等因素的影響。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 血管移植物市場：依產品類型分類

  • 生物血管移植物
    • 同種異體移植
    • 自體移植
    • 異質骨移植
  • 人工血管移植
    • 聚酯纖維
    • 聚四氟乙烯
    • 聚氨酯

第8章：血管移植市場：依血管直徑分類

  • 大的
  • 小的

第9章：血管移植市場：依適應症分類

  • 主動脈和髂動脈旁路手術
  • 腦動脈繞道手術
  • 冠狀動脈繞道術
  • 下肢搭橋手術
  • 周邊動脈旁路手術
  • 腎動脈繞道手術

第10章：血管移植市場：依最終用戶分類

  • 門診手術中心
  • 醫院和診所

第11章：血管移植市場：依通路分類

  • 離線
  • 線上

第12章 血管移植市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：血管移植市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 血管移植市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Affluent Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOVIC Sdn. Bhd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical, Inc.
  • Corcym Srl
  • CryoLife, Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe BV
  • Japan Lifeline Co., Ltd.
  • Lemaitre Vascular, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Rua Life Sciences PLC
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Terumo Corporation
  • Vascular Graft Solutions Ltd.
  • VUP Medical
  • Vygon SAS
  • WL Gore & Associates, Inc.
  • Xeltis BV
Product Code: MRR-034B50030374

The Vascular Graft Market is projected to grow by USD 2.78 billion at a CAGR of 6.44% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.80 billion
Estimated Year [2026] USD 1.90 billion
Forecast Year [2032] USD 2.78 billion
CAGR (%) 6.44%

Vascular Graft Market Introduction

The vascular graft market is advancing as cardiovascular disease, peripheral artery disease, aortic aneurysm repair, diabetes-related vascular complications, and end-stage kidney disease continue to drive demand for durable vascular access and bypass solutions. The World Health Organization identifies cardiovascular disease as the world's leading cause of death, while the International Diabetes Federation and kidney disease literature report expanding diabetes and chronic kidney disease burdens that increase the population requiring hemodialysis access, revascularization, and complex vascular reconstruction.

Market momentum is supported by the clinical use of synthetic vascular grafts such as expanded polytetrafluoroethylene (ePTFE), polyester/Dacron grafts, and increasingly sophisticated biologic and tissue-engineered alternatives. Hospitals, ambulatory surgical centers, vascular surgery departments, and dialysis access centers are prioritizing vascular graft devices that improve patency, reduce infection risk, support minimally invasive procedures, and lower reintervention rates. As healthcare systems focus on value-based outcomes, vascular graft innovation is shifting from product availability toward evidence-backed performance, procedural efficiency, and long-term patient benefit.

Transformative Shifts in the Vascular Graft Landscape

The vascular graft landscape is being reshaped by the convergence of endovascular therapy, hybrid operating rooms, advanced biomaterials, and rising demand for patient-specific treatment pathways. Traditional open surgical bypass remains essential for many complex vascular reconstruction cases, yet the growth of endovascular aneurysm repair, peripheral vascular intervention, and hybrid repair strategies is changing product requirements across graft flexibility, sealing performance, kink resistance, suture retention, and compatibility with imaging-guided workflows.

Material science is another decisive shift. Manufacturers are developing vascular grafts with improved thromboresistance, antimicrobial properties, bioactive surfaces, and better tissue integration to address complications such as thrombosis, stenosis, pseudoaneurysm formation, and surgical site infection. At the same time, procurement teams are demanding clinical evidence, total-cost-of-care justification, and supply resilience. These shifts favor organizations that combine regulatory discipline, surgeon education, robust post-market surveillance, and scalable manufacturing with differentiated vascular graft technology.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the vascular graft ecosystem across diagnosis, procedural planning, manufacturing quality control, and post-operative monitoring. AI-enabled imaging analytics can support assessment of vessel diameter, calcification, lesion morphology, aneurysm anatomy, flow dynamics, and access-site suitability, helping clinicians select graft types and plan interventions with greater consistency. In dialysis access and peripheral bypass, predictive models may help identify patients at higher risk of graft failure, stenosis, infection, or repeat intervention.

For manufacturers, AI can strengthen design optimization, simulation-driven prototyping, defect detection, process validation, and supply planning. Machine learning models can analyze real-world evidence from registries, electronic health records, imaging repositories, and claims data to evaluate vascular graft durability and complication trends. While adoption depends on data quality, regulatory acceptance, cybersecurity, interoperability, and clinician trust, AI is expected to improve decision support and lifecycle management rather than replace vascular specialists.

Key Regional Insights

North America remains a leading vascular graft market due to high procedure volumes, established reimbursement systems, advanced vascular surgery infrastructure, and strong adoption of endovascular and hybrid interventions. The United States drives regional demand through its large cardiovascular disease burden, sizeable dialysis population, and concentration of medical device innovation, while Canada emphasizes evidence-based procurement, universal healthcare access, and specialized vascular care pathways.

Europe benefits from mature hospital networks, strong clinical research activity, and regulatory oversight under the EU Medical Device Regulation, with Germany, France, Italy, Spain, and the United Kingdom supporting demand through vascular reconstruction, dialysis access, peripheral artery disease treatment, and aneurysm repair. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets invest in hospital capacity, cardiovascular care, chronic disease management, and access to advanced vascular graft devices.

Latin America, led by Brazil and Mexico, is gaining traction as public and private systems expand vascular intervention capabilities and dialysis infrastructure. The Middle East, particularly GCC countries, is investing in tertiary hospitals, specialty care, and chronic disease programs in response to high diabetes and cardiovascular risk factors. Africa shows longer-term potential as cardiovascular diagnosis, dialysis access, surgical infrastructure, and urban referral systems improve, although affordability, workforce availability, and procurement consistency remain important constraints.

Key Group Insights

The G7 represents a high-value vascular graft demand base because of aging populations, strong reimbursement pathways, mature vascular surgery capacity, advanced dialysis networks, and extensive use of innovative graft technologies. The European Union adds regulatory harmonization and cross-border clinical evidence generation, although Medical Device Regulation compliance has increased documentation, clinical evaluation, and post-market surveillance requirements for manufacturers.

BRICS countries are increasingly important as China, India, Brazil, Russia, and South Africa expand cardiovascular treatment capacity, dialysis access, and localized medical device production. ASEAN markets offer growth through rising healthcare expenditure, medical tourism hubs, and expanding renal care networks, particularly in major urban centers. GCC countries are investing in specialty hospitals and chronic disease management as diabetes, obesity, and cardiovascular risk factors remain public health priorities.

NATO member markets overlap significantly with high-income North American and European systems, supporting demand for resilient medical supply chains, quality assurance, and standardized procurement expectations for critical medical devices. Across these groups, winning strategies depend on regulatory agility, local partnerships, surgeon training, affordability, supply continuity, and credible real-world evidence demonstrating vascular graft safety, patency, and long-term clinical value.

Key Country Insights

The United States is the largest country-level opportunity, supported by high vascular procedure volumes, a substantial dialysis population, advanced reimbursement mechanisms, and strong adoption of premium medical technologies. Canada maintains steady demand through publicly funded healthcare and specialist vascular centers, while Mexico and Brazil are expanding access through mixed public-private healthcare systems, increasing cardiovascular intervention capacity, and growing demand for dialysis access solutions.

In Europe, Germany leads through advanced hospital infrastructure, high procedural capability, and medical technology adoption; France, Italy, and Spain sustain demand through established vascular care pathways and aging populations; and the United Kingdom emphasizes clinical evidence, health technology assessment, and National Health Service procurement discipline. Russia presents demand tied to cardiovascular disease burden and surgical need, although market access can be affected by geopolitical, reimbursement, and supply-chain constraints.

China and India offer major long-term growth potential due to large patient populations, rising diabetes and cardiovascular disease prevalence, and expanding hospital investment. Japan and South Korea remain innovation-oriented vascular graft markets with high quality expectations, sophisticated surgical practice, and strong clinical standards. Australia supports demand through advanced vascular services, clinical guidelines, specialist referral networks, and robust medical device regulation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated vascular graft performance supported by clinical endpoints such as primary patency, assisted patency, secondary patency, infection reduction, limb salvage, reintervention rates, and patient survival. Investment in antimicrobial coatings, heparin-bonded surfaces, bioengineered grafts, tissue-engineered vascular grafts, and small-diameter graft innovation can address persistent unmet needs in peripheral bypass and dialysis access.

Organizations should strengthen real-world evidence programs, registry participation, and health economic studies to support value-based purchasing and clinical adoption. Regional strategies should combine global quality standards with local reimbursement intelligence, clinician education, and resilient distribution. Manufacturers should also prepare for stricter regulatory scrutiny by maintaining robust post-market surveillance, product traceability, clinical documentation, and transparent risk management.

To capture emerging-market growth, leaders should develop tiered portfolios, local partnerships, and training programs that support safe adoption and appropriate patient selection. AI-enabled planning tools, digital follow-up, imaging analytics, and predictive monitoring of dialysis access can further differentiate offerings when integrated responsibly into vascular care workflows and supported by validated clinical evidence.

Research Methodology

This executive summary is based on a structured secondary research approach aligned with established standards for market intelligence. Inputs include publicly available information from health authorities, regulatory agencies, peer-reviewed clinical literature, medical device guidance, disease-burden datasets, hospital care trends, and product-category disclosures. The analysis emphasizes verified indicators such as cardiovascular disease prevalence, diabetes and chronic kidney disease trends, dialysis access requirements, vascular procedure demand, regulatory developments, and technology adoption patterns.

The methodology applies triangulation across demand-side and supply-side evidence, including clinical use cases, product categories, end-user settings, regional healthcare infrastructure, reimbursement dynamics, and competitive innovation signals. Qualitative insights were assessed for consistency across sources and interpreted through an industry framework covering product performance, market access, manufacturing scalability, regulatory readiness, and patient outcomes. No unsupported market-size claims are used; the focus is on evidence-backed drivers, restraints, and strategic implications.

Conclusion

The vascular graft market is positioned for sustained strategic importance as healthcare systems address rising cardiovascular disease, dialysis access needs, peripheral artery disease, and aneurysm repair. Demand will be shaped not only by procedure volumes but also by clinical evidence, device durability, infection prevention, graft patency, procedural efficiency, and the ability to reduce repeat interventions.

Future leadership will favor organizations that integrate advanced biomaterials, surgeon-centered design, AI-enabled insights, rigorous quality systems, and region-specific access strategies. Mature markets will continue to demand proven performance and regulatory rigor, while emerging markets will reward affordability, training, and reliable supply. As vascular care becomes more data-driven and outcomes-focused, the most competitive vascular graft strategies will be those that align innovation with measurable patient and system-level value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Vascular Graft Market, by Product Type

  • 7.1. Biological Vascular Grafts
    • 7.1.1. Allografts
    • 7.1.2. Autografts
    • 7.1.3. Xenografts
  • 7.2. Synthetic Vascular Grafts
    • 7.2.1. Polyester
    • 7.2.2. Polytetrafluoroethylene
    • 7.2.3. Polyurethane

8. Vascular Graft Market, by Blood Vessel Diameter

  • 8.1. Large
  • 8.2. Small

9. Vascular Graft Market, by Indication

  • 9.1. Aortoiliac Bypass Surgery
  • 9.2. Cerebral Artery Bypass Surgery
  • 9.3. Coronary Artery Bypass Surgery
  • 9.4. Lower Extremity Bypass Surgery
  • 9.5. Peripheral Artery Bypass Surgery
  • 9.6. Renal Artery Bypass Surgery

10. Vascular Graft Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals & Clinics

11. Vascular Graft Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Vascular Graft Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Vascular Graft Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Vascular Graft Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Affluent Medical
  • 16.3. B. Braun Melsungen AG
  • 16.4. Becton, Dickinson and Company
  • 16.5. BIOVIC Sdn. Bhd.
  • 16.6. Boston Scientific Corporation
  • 16.7. Cardinal Health Inc.
  • 16.8. Cook Medical, Inc.
  • 16.9. Corcym S.r.l.
  • 16.10. CryoLife, Inc.
  • 16.11. Endologix Inc.
  • 16.12. Getinge AB
  • 16.13. Heart Medical Europe B.V.
  • 16.14. Japan Lifeline Co., Ltd.
  • 16.15. Lemaitre Vascular, Inc.
  • 16.16. Medtronic PLC
  • 16.17. Merit Medical Systems, Inc.
  • 16.18. Rua Life Sciences PLC
  • 16.19. Shanghai Suokang Medical Implants Co. Ltd.
  • 16.20. Terumo Corporation
  • 16.21. Vascular Graft Solutions Ltd.
  • 16.22. VUP Medical
  • 16.23. Vygon SAS
  • 16.24. W. L. Gore & Associates, Inc.
  • 16.25. Xeltis B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR GRAFT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VASCULAR GRAFT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VASCULAR GRAFT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VASCULAR GRAFT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALLOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL XENOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL XENOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL XENOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SYNTHETIC VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POLYESTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POLYESTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POLYESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LARGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LARGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LARGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SMALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SMALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SMALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AORTOILIAC BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AORTOILIAC BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AORTOILIAC BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CEREBRAL ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CEREBRAL ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CEREBRAL ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LOWER EXTREMITY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOWER EXTREMITY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LOWER EXTREMITY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RENAL ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RENAL ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RENAL ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. GCC VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 128. GCC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 129. GCC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GCC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. G7 VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 152. G7 VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 153. G7 VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 155. G7 VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. G7 VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. NATO VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. NATO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 160. NATO VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 161. NATO VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 162. NATO VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 163. NATO VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. CANADA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 177. CANADA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 178. CANADA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 179. CANADA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 180. CANADA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. CANADA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. MEXICO VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 185. MEXICO VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 186. MEXICO VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 187. MEXICO VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 188. MEXICO VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MEXICO VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. BRAZIL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 193. BRAZIL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 194. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 195. BRAZIL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRAZIL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GERMANY VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 209. GERMANY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 210. GERMANY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 211. GERMANY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GERMANY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GERMANY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. FRANCE VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 217. FRANCE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 218. FRANCE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 219. FRANCE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 220. FRANCE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. FRANCE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. RUSSIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. RUSSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 225. RUSSIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 226. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 227. RUSSIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 228. RUSSIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. RUSSIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. ITALY VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 233. ITALY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 234. ITALY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 235. ITALY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 236. ITALY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. ITALY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. SPAIN VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. SPAIN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. SPAIN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 241. SPAIN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 242. SPAIN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 243. SPAIN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 244. SPAIN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. SPAIN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. INDIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 257. INDIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 258. INDIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 259. INDIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 260. INDIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. INDIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. JAPAN VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 265. JAPAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 266. JAPAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 267. JAPAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 268. JAPAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. JAPAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. AUSTRALIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 273. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 274. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 275. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 276. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 281. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 282. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 283. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 284. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)